In contemporary ICUs, insulin therapy is commonly guided by intermittent blood gas glucose analyses, which has a significant impact on staff workload and may counteract timely recognition of hypoglycemia and attenuation of glucose variability. The gene discussed is INS; the disease is Hypoglycemia.